About DISCGENICS INC
REVOLUTIONIZING CARE FOR CHRONIC BACK PAIN
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Salt Lake City, Utah
- Founded
- 2007
- Company type
- Privately Held
- Company profile name
- DiscGenics
DiscGenics is a privately held, clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine.
DiscGenics is harnessing the restorative potential of cells native to the intervertebral disc to develop what we hope will be a profound therapeutic option for millions of patients suffering from the debilitating effects of back pain.
DiscGenics’ first product candidate, IDCT, is a homologous, allogeneic, injectable cell therapy for the treatment of patients with mild to moderate degenerative disc disease.
Company locations
5940 W Harold Gatty Dr, Salt Lake City, Utah 84116, US
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
On LinkedIn
- Followers
- 3,737
- People linked to this company
- 39
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.